Patents by Inventor Claudia C. Roskopf

Claudia C. Roskopf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD33-, CD16- and CD123-specific single chain triplebody
    Patent number: 11945863
    Abstract: The present invention relates to a nucleic acid molecule encoding a chain myeloid capable of specifically binding to CD33, CD16 and CD123, wherein said nucleic molecule comprises: (a) a nucleic add molecule encoding a protein represented by SEQ ID NO:1; (b) a nucleic acid molecule represented by SEQ ID NO:2; (c) the nucleic add molecule of (b), wherein each thymine is replaced by urea; (d) a nucleic acid molecule encoding a protein having at least 98% sequence identity to the protein of (a); or (e) a nucleic add molecule that is degenerate with respect to the nucleic acid molecule of (b) or (c). The present invention further relates to a vector comprising the nucleic acid molecule of the invention, a host cell transformed or transfected with the nucleic acid molecule or the vector of the invention, as well as to a method for the production of a single chain myeloid capable of specifically binding to CD33, CD16 and CD123.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: April 2, 2024
    Assignee: Friedrich-Alexander-Universität Erlangen-Nürnberg
    Inventors: Georg H. Fey, Todd Braciak, Claudia C. Roskopf, Ingo Schubert, Karl-Peter Hopfner, Nadja Fenn, Sarah Wildenhain, Uwe Jacob